Continuous subcutaneous infusion of Glucagon-like Peptide-1 (GLP-1) lowers plasma glucose and reduces appetite in type II diabetic patients
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Continuous subcutaneous infusion of Glucagon-like Peptide-1 (GLP-1) lowers plasma glucose and reduces appetite in type II diabetic patients. / Toft-Nielsen, M.B.; Madsbad, S.; Holst, J.J.
In: Diabetes Care, No. 22, 1999, p. 1137-1143.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Toft-Nielsen, MB, Madsbad, S & Holst, JJ 1999, 'Continuous subcutaneous infusion of Glucagon-like Peptide-1 (GLP-1) lowers plasma glucose and reduces appetite in type II diabetic patients', Diabetes Care, no. 22, pp. 1137-1143.
APA
Toft-Nielsen, M. B., Madsbad, S., & Holst, J. J. (1999). Continuous subcutaneous infusion of Glucagon-like Peptide-1 (GLP-1) lowers plasma glucose and reduces appetite in type II diabetic patients. Diabetes Care, (22), 1137-1143.
Vancouver
Toft-Nielsen MB, Madsbad S, Holst JJ. Continuous subcutaneous infusion of Glucagon-like Peptide-1 (GLP-1) lowers plasma glucose and reduces appetite in type II diabetic patients. Diabetes Care. 1999;(22):1137-1143.
Author
Bibtex
@article{fd94a4e074c811dbbee902004c4f4f50,
title = "Continuous subcutaneous infusion of Glucagon-like Peptide-1 (GLP-1) lowers plasma glucose and reduces appetite in type II diabetic patients",
author = "M.B. Toft-Nielsen and S. Madsbad and J.J. Holst",
year = "1999",
language = "English",
pages = "1137--1143",
journal = "Diabetes Care",
issn = "0149-5992",
publisher = "American Diabetes Association",
number = "22",
}
RIS
TY - JOUR
T1 - Continuous subcutaneous infusion of Glucagon-like Peptide-1 (GLP-1) lowers plasma glucose and reduces appetite in type II diabetic patients
AU - Toft-Nielsen, M.B.
AU - Madsbad, S.
AU - Holst, J.J.
PY - 1999
Y1 - 1999
M3 - Journal article
SP - 1137
EP - 1143
JO - Diabetes Care
JF - Diabetes Care
SN - 0149-5992
IS - 22
ER -
ID: 192007